National Institutes of Health: all 11,571 studies

Page 85 of 116. Open to participants first (945), then studies with results posted, then the rest; newest registration first within each.

• Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck CancerTerminatedNCT00033449Phase 1
• Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon CancerCompletedNCT00033358Phase 2
• Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple MyelomaCompletedNCT00033332Phase 3
• CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's LymphomaCompletedNCT00033267Phase 2
• Radiation Therapy With or Without Thalidomide in Treating Patients With Brain MetastasesCompletedNCT00033254Phase 3
• Immune Restoration by Lipoic Acid in AIDSCompletedNCT00033176Phase 2
• A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIVCompletedNCT00033163Phase 2
• A Comparison of Language Intervention ProgramsCompletedNCT00033150Phase 3
• A Behavioral Trial for the Treatment of Methamphetamine Dependence. - 1Status unknownNCT00033124Phase 2
• A Study of Cabergoline for the Treatment of Cocaine Dependence - 1CompletedNCT00033111Phase 2
• Cocaine-Metyrapone Interaction Study - 1Status unknownNCT00033098Phase 1
• Ondansetron for the Treatment of Cocaine Dependence - 1CompletedNCT00033085Phase 2
• Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1Status unknownNCT00033072Phase 1
• Assessment of Potential Interactions Between Cocaine and Tolcapone - 1Status unknownNCT00033059Phase 1
• Evaluation of Modafinil as a Cocaine Treatment Medication and Interactions With Cocaine - 1Status unknownNCT00033046Phase 1
• Reserpine for the Treatment of Cocaine Dependence - 1CompletedNCT00033033Phase 2
• Lofexidine for Opiate Withdrawal - 1CompletedNCT00032942Phase 3
• Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1CompletedNCT00032929Phase 3
• Drug Interaction Study With NS2359 and Cocaine in Cocaine Experienced Volunteers - 1Status unknownNCT00032916Phase 1
• Genetic Analysis of Fraser Syndrome and Fryns SyndromeCompletedNCT00032877
• Effects of Stress Hormones on Emotion and CognitionCompletedNCT00032838
• Ketoconazole Plus Docetaxel to Treat Prostate CancerCompletedNCT00032825Phase 1
• The Role of Dopamine in Motor Learning in Healthy Subjects and Patients With Parkinson's DiseaseCompletedNCT00032812
• Meditation-Based Treatment for Binge Eating DisorderCompletedNCT00032760Phase 2/3
• The Use of Reiki for Patients With Advanced AIDSCompletedNCT00032721Phase 2
• Dryvax Dilution-Prev Vacc AdultsCompletedNCT00032708Phase 2
• Treatment of AIDS Vacuolar Myelopathy With MethionineCompletedNCT00032695Phase 3
• Constipation in Pediatric Cancer Patients Receiving Vinca Alkaloids or NarcoticsCompletedNCT00032682
• Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected ChildrenCompletedNCT00032669Phase 1
• Adolescents' Use of Complementary and Alternative MedicineCompletedNCT00032656
• Classical Conditioning to Treat Allergic Airway DiseasesStatus unknownNCT00032526Not applicable
• Evaluation of Echinacea for the Common ColdCompletedNCT00032500Phase 2
• Ginkgo Biloba Extract and the Insulin Resistance SyndromeCompletedNCT00032474Phase 1/2
• Acupuncture in Cardiovascular DiseaseCompletedNCT00032422Phase 2
• The Effects of Music Therapy-Based Stress Reduction on Bone Marrow Transplant RecipientsCompletedNCT00032409Phase 2
• Complementary/Alternative Medicine for Abnormality in the Vestibular (Balance) SystemCompletedNCT00032383Phase 1/2
• Cell Lines From High-Risk Breast TissueCompletedNCT00032201
• Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney CancerCompletedNCT00032188Phase 2
• Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal CancerCompletedNCT00032110Phase 2
• Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the BrainCompletedNCT00032097Phase 1
• Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV MelanomaCompletedNCT00032045Phase 2
• Erlotinib in Treating Patients With Persistent or Recurrent Cancer of the CervixCompletedNCT00031993Phase 2
• CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous TherapyCompletedNCT00031941Phase 1
• Mafosfamide in Treating Patients With Progressive or Refractory Meningeal TumorsCompletedNCT00031928Phase 1
• Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone SarcomaCompletedNCT00031915Phase 2
• 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)CompletedNCT00031681Phase 1
• Genetic Analysis of Brain TumorsTerminatedNCT00031538
• Pleconaril Enteroviral Sepsis SyndromeCompletedNCT00031512Phase 2
• Azithromycin/Bicillin SyphilisCompletedNCT00031499Phase 3
• Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant PatientsTerminatedNCT00031473Phase 3
• Valganciclovir in Congenital CMV InfantsCompletedNCT00031434Phase 1/2
• Neonatal CMV-Ganciclovir Follow-up StudyCompletedNCT00031421
• Imaging Study of Automatic MovementsCompletedNCT00031382
• Brain Anatomy in DystoniaTerminatedNCT00031369
• The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and RibavirinCompletedNCT00031343Phase 2
• Evaluation of Clonazepam and Paroxetine for Panic Disorder With DepressionCompletedNCT00031317Phase 4
• Screening Protocol for HIV Vaccine StudiesCompletedNCT00031304
• Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune GlobulinCompletedNCT00031291
• Efficacy of a Family Telephone Intervention for StrokeCompletedNCT00031265Phase 2
• Sleep Apnea in Look AHEAD Participants - Ancillary to Look AHEADCompletedNCT00031239
• Heavy Metals, Obesity and Cardiovascular Risk - Ancillary to Look AHEADCompletedNCT00031213
• MRI Derived Organ & Tissue Mass Changes With Weight Loss - Ancillary to Look AHEADCompletedNCT00031200
• Blood Component Collection From Patients With Rheumatic or Kidney Disease and Healthy VolunteersTerminatedNCT00031174
• Study of Genetic Risk Factors for Spina Bifida and AnencephalyStatus unknownNCT00031122
• The Effectiveness of Human Antibodies in Influencing an AIDS-Like Disease in MonkeysCompletedNCT00031109Not applicable
• Increasing HAART-Induced Immune Restoration With CyclosporineCompletedNCT00031070Phase 2
• Vitamin B Therapy for HyperlactatemiaCompletedNCT00031057Not applicable
• Adding New Drugs for HIV Infected Patients Failing Current TherapyCompletedNCT00031044Phase 1/2
• Prevention of Cognitive Decline in Alzheimer's Disease by Ingested Interferon AlphaStatus unknownNCT00031018Phase 2
• Stem Cell Transplantation to Treat Leukocyte Adhesion DeficiencyCompletedNCT00031005Phase 2
• Donepezil to Treat Dementia in Parkinson's DiseaseCompletedNCT00030979Phase 4
• Magnetic Resonance Spectroscopy to Evaluate Tourette s SyndromeCompletedNCT00030953
• Cause, Development, and Progression of Stiff-Person SyndromeCompletedNCT00030940
• Vaccine Therapy in Treating Patients With Metastatic Solid TumorsTerminatedNCT00030693Phase 1
• Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of ChildhoodCompletedNCT00030667Phase 2
• Decitabine in Treating Patients With Advanced Solid TumorsCompletedNCT00030615Phase 1
• Erlotinib in Treating Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT00030537Phase 2
• Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionCompletedNCT00030498Phase 1
• Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial CancerCompletedNCT00030485Phase 2
• Imatinib Mesylate in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00030394Phase 2
• Iododoxorubicin in Treating Patients With Primary Systemic AmyloidosisTerminatedNCT00030381Phase 1
• Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00030368Phase 1
• Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic LeukemiaWithdrawnNCT00030355Phase 1/2
• Supplemental Calcium in Overweight PeopleCompletedNCT00030238Phase 3
• Immune Abnormalities in Sporadic Inclusion Body MyositisCompletedNCT00030212
• Brain Control of BlinkingCompletedNCT00030199
• Strength Training for Obesity PreventionCompletedNCT00030160Phase 2
• Data Collection in Women With Fabry DiseaseCompletedNCT00030134
• Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to TherapyCompletedNCT00030108Phase 1
• 2-Methoxyestradiol in Treating Patients With Advanced Solid TumorsCompletedNCT00030095Phase 1
• Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver CancerCompletedNCT00030082Phase 1
• Evaluating Silymarin for Chronic Hepatitis CCompletedNCT00030030Phase 2
• Pilot Study of Spinal Manipulation for Chronic Neck PainTerminatedNCT00030004Phase 1
• Extract of Ginkgo Biloba (EGB 761) and Vascular FunctionCompletedNCT00029991Phase 1/2
• Transfer of Neural Energy Between HumansCompletedNCT00029978
• Long Term Post Operative Follow-Up of Cushing SyndromeCompletedNCT00029952
• Brain Activity During Production of MovementCompletedNCT00029939
• Positron Emission Tomography (PET) to Locate Areas of White Blood Cell ActivityCompletedNCT00029926
• Chinese Exercise Modalities in Parkinson's DiseaseCompletedNCT00029809Phase 1/2
• Isoflavones and Acute-phase Response in Chronic Renal FailureCompletedNCT00029796Phase 2

← National Institutes of Health overview and focus areas